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Abstract
Background: Evidence for the impact of inappropriate antimicrobial therapy on bacteremia is mainly from studies
in medical centers. We investigated the impact of inappropriate antimicrobial therapy on bacteremia in a
community hospital. In particular, patients from the hospital’s affiliated nursing home were sent to the hospital with
adequate referral information.
Methods: We performed a retrospective study to collect data of patients with bacteremia in a community hospital
in Taiwan from 2005 to 2007.
Results: A total of 222 patients with blood stream infection were diagnosed, of whom 104 patients (46.8%) died.
The rate of initial inappropriate antibiotic prescriptions was high (59%). Multivariate analysis revealed that patients
with initial inappropriate antibiotics, patients with ventilator support and patients requiring ICU care were the
independent predictors for inhospital mortality. Patients referred from the hospital-affiliated nursing home and
patients with normal WBC counts had better survival outcome. More than 80% cases infected with methicillin-
resistant Staphylococcus aureus (MRSA) and Enterococcus faecalis received initial inappropriate antimicrobial therapy.
With the longer delay to administer appropriate antibiotic, a trend of higher mortality rates was observed.
Conclusions: Bacteremia patients from a hospital-affiliated nursing home had a better prognosis, which may have
been due to the adequate referral information. Clinicians should be aware of the commonly ignored drug resistant
pathogens, and efforts should be made to avoid delaying the administration of appropriate antibiotic therapy.
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Background
Blood stream infections (BSI) are a major cause of mor-
bidity and mortality, and they are also associated with
an increased one-year mortality rate [1]. Two import-
ant factors for the decreased efficacy of antimicrobial
therapy are treatment with inappropriate antimicro-
bial agents and the delay of appropriate antimicrobial
therapy [2]. However, the increasing antimicrobial resist-
ance of micro-organisms has decreased the likelihood
of patients receiving appropriate empiric antimicrobial
therapy.
Many studies have reported that inappropriate empirical
antimicrobial treatment for BSI resulted in higher patient
morbidity and mortality rates and increased healthcare
costs [1,3-11]. Most of these studies were conducted in
medical centers and university hospitals. However, other
studies have failed to find a relationship between mortality
and initial inappropriate antibiotic treatment in BSI pa-
tients [12,13]. The conflicting findings may be due to dif-
ferent rates of inappropriate antimicrobial therapy, the
case number in each study, differences in disease severity
and comorbidities of the patients, and differences in hos-
pital care systems [14]. It is therefore interesting to investi-
gate the influencing factors in different hospital settings
and healthcare systems.
Studies of the impact of inadequacy of antibiotics on
BSI patients in medical centers in Taiwan have been
reported [3,6,15]. However, no studies have focused on
community hospital setting. In addition, the correl-
ation of BSI outcomes and different BSI case sources
(communities, nursing homes, and hospitals) has never
been documented. A current trend in Taiwan is for a
hospital to have an affiliated or contracted nursing
home that may or may not include respiratory care
wards. It is possible for BSI patients who are referred
from an affiliated nursing home to the parent hospital
to have an advantage over patients admitted directly
to the hospital for BSI because healthcare workers of
the affiliated nursing home provide patients’ medical
information. However, this has not been thoroughly
studied before.
We performed this retrospective study in a community
hospital in Taiwan. The hospital received cases from the
community, including those from the hospital affiliated
nursing home with which there was good communica-
tion and 24-hour physician coverage. All of the patients
residing at the nursing home were sent to the parent
hospital when they became ill.
The aim of this study was to analyze the impact of ini-
tial inappropriate or appropriate antibiotic treatment, fo-
cusing on mortality, pathogens and clinical parameters.
We also investigated the epidemiology, microbiology and
prognosis in community acquired, nursing home acquired
and hospital acquired blood stream infections.
Methods
Study location and patient selection
This study was conducted at Wen-Hsiung Hospital,
which is a community hospital located in Kaohsiung,
Taiwan. There is a 20-bed respiratory care ward, a 6-bed
intensive care unit and a 26-bed ordinary ward in the
hospital. Patients in a 128-bed nursing home which is af-
filiated to Wen-Hsiung Hospital are sent to the hospital
when medical needs arise. Patients in the affiliated nurs-
ing home are cared for by at least one staff physician
from the community hospital either in-house or on-call
at all times. For there was no Institute Ethics Committee
at the community hospital, this work was approved by
the Institute Ethics Committee of Kaohsiung Medical
University Hospital (KMUH-IRB-2013003) according to
Taiwan national regulation.
All cases of bacteremia were divided into three sources:
community acquired, hospital acquired and nursing home
acquired. The patients were identified by review of micro-
biology laboratory records from January 1, 2005 through
December 31, 2007. They were included in the study if
their blood cultures were drawn either at the hospital or
in the emergency department immediately prior to admis-
sion, and if the culture results were positive for a fungus
or bacteria. Patients younger than 18 years and patients
who visited the emergency department but were not hos-
pitalized were excluded. All case records were reviewed by
two physicians (Dr. Yang CJ and Dr. Chung YC). All of the
clinical and mortality data were obtained from the pa-
tients’ medical records as well as their charts.
Definition and data collection
Bloodstream infections was diagnosed by the presence of
clinical or laboratory evidence of sepsis. The definition of
sepsis was based on the ACCP/SCCM consensus confer-
ence committee [16]. The possibility of a contaminated
blood culture was determined after agreement by two
doctors. A community-acquired BSI was defined when
bacteremia occurred within the first 48 hours of hospital
admission for patients from the local community. A nurs-
ing home-acquired BSI was defined when it occurred at
the time of hospital admission or within 48 hours of ad-
mission for patients who came from the hospital affiliated
nursing home. A hospital-acquired BSI was defined when
it occurred more than 48 hours after the beginning of a
period of hospitalization. Patients who were transferred
from other hospitals or other nursing homes were ex-
cluded from the study. In addition, polymicrobial blood
stream infections were also excluded.
Mortality was the main outcome. Appropriate antibiotic
therapy was defined as the initial antimicrobial agent being
active in vitro against the infecting organism, and if the
drug was given at an appropriate dose and by appropriate
route of administration. Initial therapy was defined as the
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antibiotics received on the first day of therapy for the BSI.
Time to appropriate antibiotic administration was re-
corded in the inappropriate therapy group.
Information with regards to comorbid medical condi-
tions such as diabetes mellitus, malignancy, chronic ob-
structive pulmonary disease, liver cirrhosis, ventilator
support, end stage renal disease, vascular disease (in-
cluding coronary artery disease and cerebral vascular
disease) were documented. The other recorded vari-
ables were age, sex, source of infection, leukocytes, use
of catheters, tracheostomy status, steroid use, postoper-
ative status, length of stay more than 30 days, hospi-
talized site, sepsis status (sepsis, severe sepsis, septic
shock and multiple organ dysfunction syndrome), micro-
organism isolates, CURB-65 score items including con-
fusion, blood urine nitrogen > 20 mg/dl, shock status
(systolic blood pressure > 90 mmHg or diastolic pres-
sure < 60 mmHg), respiratory rate > 30 per minute) [17]
and the different sources include community, hospital and
the hospital affiliated nursing home. The referral medical
information from nursing homes included hospitalization
history, previous culture report, and recent infection sites,
Antimicrobial susceptibility testing of the BSI isolates
was performed according to the National Committee for
Clinical Laboratory standards [18].
Statistical analysis
Descriptive statistics were implemented to summarize
the patient characteristics as mean (SD) or proportions.
The chi-square or Fisher’s exact test for the categorical
data and the Student’s t-test or Mann–Whitney U test
for the continuous data were used to compare data be-
tween different groups. In the multivariaate analysis, we
analyzed variables with a P value <0.05 from the univari-
ate analysis. To control for potential confounding factors,
a multinominal logistic regression analysis was per-
formed evaluating the possible covariates. A P value of less
than 0.05 was considered to be statistically significant.
SPSS version 14.0 software (SPSS Inc., Chicago, IL, USA)
was used for data analysis.
Results
Between January 1, 2005 and December 31, 2007, a total of
222 cases of BSI were diagnosed at the hospital. Thirty-six
patients had community-acquired, 129 patients had
hospital-acquired, and 57 patients had nursing home-
acquired BSI. The initial inappropriate antibiotic pre-
scription rate was 59% (131/222). One hundred and four
patients (46.8%) died during their hospitalization. Among
the three sources, hospital-acquired acquired bacteremia
had the worst prognosis with a mortality rate of 58.91%,
and patients with nursing home-acquired BSI had the best
prognosis, with a mortality rate of 26.3%. In the nursing
home-acquired group, the four most common patho-
gens were Escherichia coli (16 cases, 28.07%), Klebsiella
pneumoniae (5 cases, 8.77%), Proteus mirabilis (5 cases,
8.77%) and Methicillin susceptible Staphylococcus aureus
(MSSA) (5 cases, 8.77%). The most common sources of in-
fection were urinary tract infections (23 cases, 40.35%) and
respiratory tract infections (20 cases, 35.08%).
Table 1 The demographics, co-morbidities and medical devices used when the bacteremia occurred of the inhospital
survivors and non-survivors
Factors Survivors (n = 118) Non-survivors (n = 104) OR 95% CI P value
Age 68.78+/−16.65 74.88+/−11.07 <0.01
Male gender 74 (62.7%) 55 (52.9%) 0.667 0.390-1.141 0.18
DM 53 (44.9%) 54 (51.9%) 1.325 0.781-2.247 0.36
Malignancy 15 (12.7%) 15 (14.4%) 1.157 0.536-2.499 0.86
LC 9 (7.6%) 7 (6.7%) 0.874 0.314-2.436 1.00
Ventilator use 41 (34.7%) 65 (62.5%) 3.130 1.808-5.419 <0.01
ESRD 14 (11.9%) 27 (26.0%) 2.605 1.281-5.296 0.01
COPD 31 (26.3%) 19 (18.3%) 0.627 0.329-1.195 0.21
Vascular Disease 79 (66.9%) 72 (69.2%) 1.111 0.631-1.957 0.83
Transplantation 0 0
Foley 53 (44.9%) 57 (54.8%) 1.487 0.876-2.526 0.18
Tracheostomy 50 (42.4%) 58 (55.8%) 1.715 1.007-2.919 0.06
CVC 37 (31.4%) 56 (53.8%) 2.554 1.477-4.416 <0.01
Hemocatheter 6 (5.1%) 11 (10.6%) 2.208 0.787-6.197 0.20
Steroid 5 (4.2%) 5 (4.8%) 1.141 0.321-4.059 1.00
Post-OP 1 (0.8%) 1 (1.0%) 1.136 0.070-18.391 1.00
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Univariate analysis of the demographics, comorbidi-
ties, laboratory data, sources of infection, sepsis status,
admission site and adequacy of the antibiotic treatment
with regards to survival and mortality is present in
Table 1 and Table 2. Hospital mortality was correlated
with older age, higher serum creatinine, lower serum al-
bumin, more ventilator support and more central venous
catheterization. The mortality rate was higher in those with
a serum white blood cell count > 20 × 103/ul, length of
hospital stay > 30 days, hospitalized in the intensive care
unit, with septic shock, confused status, blood urine ni-
trogen > 20 mg/dL, systolic BP < 90 mmHg or diastolic
BP < 60 mmHg, nosocomial infection and inappropriate
antibiotic treatment. In contrast, those with a normal
white blood cell count (between 4 × 103 to 10 × 103/ul),
admitted to the ordinary ward, sepsis status and with nurs-
ing home-acquired BSI were more likely to survive.
After excluding CURB-65 parameters (confusion,
BUN >20, RR > 30, SBP <90, DBP <60) and septic status
(sepsis, severe sepsis, septic shock, MODS), the multivariate
Table 2 The laboratory data, sources of infection, sepsis status, admission site and initial inappropriate antibiotic use
among the inhospital survivors and non-survivors
Factors Survivors (n = 118) Non-survivors (n = 104) OR 95% CI P value
WBC ( /uL)
<4000 8 (7.0%) 6 (5.9%) 0.828 0.277-2.473 0.95
4000-10000 42 (36.8%) 16 (15.7%) 0.319 0.166-0.614 <0.01
10000-20000 50 (43.9%) 51 (50.0%) 1.280 0.749-2.188 0.44
>20000 14 (12.3%) 29 (28.4%) 2.838 1.401-5.746 <0.01
Creatinine 1.68 ± 1.35 2.56 ± 1.56 <0.01
Albumin 3.08 ± 0.53 2.84 ± 0.52 <0.01
C-reactive protein 10.10 ± 7.15 13.39 ± 7.92 0.03
Thrombocytopenia 6 (5.1%) 5 (4.8%) 0.943 0.279-3.184 1.00
Pulmonary infection 25 (21.2%) 33 (31.7%) 1.729 0.945-3.165 0.10
UTI 39 (33.1%) 26 (25.0%) 0.675 0.376-1.214 0.24
IAI 8 (6.8%) 1 (1.0%) 0.133 0.016-1.086 0.04
SSTI 8 (6.8%) 9 (8.7%) 1.303 0.483-3.510 0.79
SWI 0 0
CRBSI 14 (11.9%) 14 (13.5%) 1.156 0.523-2.553 0.88
CNS infection 0 0
Unknown infection focus 24 (20.3%) 23 (22.1%) 1.112 0.584-2.119 0.87
Initial inappropriate antibiotic use 59 (50.0%) 72 (69.2%) 2.250 1.297-3.904 <0.01
Sepsis 84 (71.2%) 34 (32.7%) 0.197 0.111-0.348 <0.01
Severe Sepsis 20 (16.9%) 20 (19.2%) 1.167 0.588-2.314 0.79
Septic Shock 9 (7.6%) 44 (42.3%) 8.881 4.06-19.44 <0.01
MODS - 5 (4.8%) - - 0.02
Confusion 79 (66.9%) 96 (92.3%) 5.924 2.62-13.41 <0.01
RR >30 (per minute) 27 (22.9%) 34 (32.7%) 1.637 0.904-2.964 0.14
BUN >20 (mg/dl) 79 (66.9%) 92 (88.5%) 3.785 1.854-7.725 <0.01
SBP <90 mmHg or DBP <60 mmHg 17 (14.4%) 52 (50.0%) 5.941 3.13-11.29 <0.01
Community - acquired 24 (20.3%) 12 (11.5%) 0.511 0.241-1.082 0.11
Nursing home – acquired 42 (35.6%) 15 (14.4%) 0.305 0.157-0.593 <0.01
Hospital – acquired 53 (44.9%) 76 (73.1%) 3.329 1.892-5.857 <0.01
ICU stay 17 (14.4%) 45 (43.3%) 4.531 2.380-8.626 <0.01
LOS > 30 days 34 (28.8%) 51 (49.0%) 2.377 1.367-4.136 <0.01
WBC White cell counts, UTI Urinary tract infection, IAI Intra-abdominal infection, SSTI Superficial soft infection, CRBSI Catheter related blood stream infection, CNS
Central venous infection, CVC Central venous catheter, OP Operation, LOS Length of stay, MODS Multiple organ dysfunction syndrome, RR Respiratory rate, BUN
Blood urea unit, SBP Systolic blood pressure, DBP Diastolic blood pressure. Except for two variables including LOS > 30 days and ICU stay (ICU care is required
during hospitalization), all the variables were measured when bacteremia occurred.
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analysis revealed that the patients from nursing home (OR
0.267, 95% CI 0.091-0.970, P = 0.044), and normal WBC
(OR 0.198, CI 0.068-0.574, P = 0.003) were significant for
better outcome. In contrast, the patients with Initial in-
appropriate antibiotics use (OR 3.715, 95% CI 1.736-7.948,
P = 0.001). In other hand, patients admitted to ICU (OR
4.241, 95% CI 1.620-11.104, P = 0.003) and needed ventila-
tor use (OR 3.290, CI 1.034-10.466, P = 0.044) had the
worst prognosis (Table 3). Furthermore, initial inappropri-
ate antibiotic administration was significant associated with
a higher mortality rate (Log Rank Test, P = 0.018) (Figure 1)
and delayed appropriate antibiotic administration was asso-
ciated with a trend of a higher mortality rate (P = 0.07)
(Figure 2).
The pathogen related mortality rate and ratio of in-
appropriate antibiotic use are shown in Table 4. The
most common pathogens in the study were E. coli (42
cases), K. pneumoniae (34 cases), MRSA (31 cases), and
Burkholderia cepacia (23 cases). There was an outbreak of
B. cepacia infection in the hospital between 2006 and
2007 [19]. The pathogens with mortality rates of more than
50% included MRSA, coagulase negative Staphylococcus,
Streptococcus pneumoniae, Viridans Streptococcus, Entero-
coccus faecalis, Klebsiella pneumoniae, Enterobacter aero-
genes, Serratia marcescens, Citrobacter spp., Hemophilus
influenzae, Pseudomonas aeruginosa and Acinetobacter
baumannii. For the species with at least 10 isolates in the
study, cases infected with MRSA and Enterococcus faecalis
had more than 80% chance to receive initial inappropriate
antimicrobial therapy.
The most common inappropriate antibiotics used were
cefazolin (57 cases, 43.5%), gentamicin (49 cases, 37.4%),
and amoxicillin/clavulanate (35 cases 26.7%) (Table 5).
For the other antibiotics, the rates were less than 10%.
The 30-day mortality rate and the analysis of factors
associated with 30-day mortality were provided in the
supplemental data (Table 6).
Discussion
This is the first report about inappropriate antibiotic use
and outcomes of cases of bacteremia in a community hos-
pital in Taiwan. Multiple drug resistant microorganisms
were frequently encountered in the island nation [20,21].
A high rate (59%) of initial inappropriate antibiotic use
was observed, which is higher than most published studies
[1,3-11] and have led to the poor outcomes. We observed
that nursing home-acquired BSI cases had the best prog-
nosis when compared to the hospital-acquired and
community-acquired BSI groups. Patients with ventilator
support and patients requiring ICU care were the inde-
pendent predictors for inhospital mortality. Patients with
normal WBC counts had better survival outcome. Delayed
appropriate antibiotic administration was found to be as-
sociated with a higher mortality rate.
One of the major causes of inappropriate initial anti-
microbial therapy was the ignorance of the possibility of
Table 3 Significant factors associated with mortality in
multivariate analysis
OR 95% CI P value
Nursing home 0.267 0.091-0.970 0.044
WBC 4000–10000 /uL 0.198 0.068-0.574 0.003
Initial inappropriate antibiotic use 3.715 1.736-7.948 0.001
ICU stay 4.241 1.620-11.104 0.003
Ventilator use 3.290 1.034-10.466 0.044
Figure 1 Initial inappropriate antibiotic administration was
significant associated with a higher mortality rate (Log Rank
Test, P = 0.018).
Figure 2 In the inappropriate antibiotic treatment group,
delayed adequate antibiotics administration led to higher in-
hospital mortality (Chi-square test for trend, P = 0.07).
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antimicrobial-resistant organisms causing the infections.
Only 16.2% (36/222) of the BSI in the study was
community-acquired. Not surprisingly, cefazolin, genta-
micin and amoxicillin/clavulanate were the most com-
monly used initially and inappropriate antibiotics when
most bacteremia episodes were healthcare associated.
These drugs are frequently prescribed empirically in
Taiwan due to the low cost. The regulations of the Na-
tional Health Insurance (NHI) authority in Taiwan may
have contributed to this prescription habit. Almost all
hospitals in Taiwan are included in the reimbursement
system of the NHI. The amount of reimbursement for
each hospital is usually fixed every year, and the NHI re-
fuses to reimburse the medical expenditure when the ex-
pense is higher than the fixed amount [22]. All hospitals
are requested to reduce cost; therefore, newer antimicro-
bial agents those may cost more are restricted from be-
ing used as the initial antibiotics in some hospitals. Even
though most antimicrobial resistance surveillance stud-
ies show that the major pathogens in Taiwan are resist-
ant to the first or secondary generations of beta-lactams
and aminoglycosides [20,23,24], cefazolin, gentamicin and
Table 4 The pathogen related mortality and the ratio of inadequate antibiotics
Mortality Initial inappropriate antibiotic use Association of mortality and initial
inappropriate antibiotic use
N (%) N (%) (P value)
Gram(+) bacteria
Staphylococcus aureus 21/38 (55.3%) 25/38 (65.8%) 0.011
MSSA 1/7 (14.3%) 0/7 (0.0%) -
MRSA 20/31 (64.5%) 25/31 (80.6%) 0.151
Coagulase-negative Staphylococcus 3/5 (60.0%) 3/5 (60.0%) 1.000
Beta-hemolytic Streptococcus (Non Group A or B) 0/1 (0.0%) 0/1 (0.0%) -
Streptococcus pneumoniae 2/2 (100.0%) 0/2 (0.0%) -
Viridans Streptococcus 2/3 (66.7%) 0/3 (0.0%) -
Enterococcus faecalis 5/10 (50.0%) 9/10 (90.0%) 1.000
Corynebacterium spp. 0/7 (0.0%) 3/7 (42.9%) -
Enterobacteriaceae
Escherichia coli 16/42 (38.1%) 21/42 (50.0%) 0.340
Klebsiella pneumoniae 21/34 (61.8%) 23/34 (67.6%) 1.000
Proteus mirabilis 4/10 (40.0%) 6/10 (60.0%) 1.000
Enterobacter cloacae 0/1 (0.0%) 1/1 (100.0%) -
Enterobacter aerogenes 3/6 (50.0%) 4/6 (66.7%) 0.400
Serratia marcescens 2/4 (50.0%) 3/4 (75.0%) 1.000
Non-typhoidal Salmonella 1/4 (25.0%) 2/4 (50.0%) 1.000
Providencia rettgeri 1/3 (33.3%) 2/3 (66.7%) 0.333
Morganella morganii 0/3 (0.0%) 1/3 (33.3%) -
Citrobacter spp. 1/1 (100.0%) 1/1 (100.0%) -
Haemophilus influenzae 1/1 (100.0%) 1/1 (100.0%) -
Glucose Non-fermenter
Pseudomonas aeruginosa 4/7 (57.1%) 5/7 (71.4%) 1.000
Burkholderia cepacia 8/23 (34.8%) 12/23 (52.2%) 0.193
Acinetobacter baumannii 6/8 (75.0%) 5/8 (62.5%) 1.000
Stenotrophomonas maltophilia 1/1 (100.0%) 0/1 (0.0%) -
Anaerobes
Peptostreptococcus spp. 0/2 (0.0%) 1/2 (50.0%) -
Propionibacterium spp. 0/4 (0.0%) 2/4 (50.0%) -
Candida spp 2/2 (100.0%) 1/2 (50.0%) -
MRSA Methicillin resistant Staphylococcus aureus, MSSA Methicillin susceptible Staphylococcus aureus.
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amoxicillin/clavulanate are still common choices of empiric
antibiotics in community hospitals. Our result alerts clini-
cians to notice impact on patient outcomes due to in-
appropriate antibiotic administration. It is also necessary to
improve the physicians’ appropriate use of costlier antimi-
crobials when patients with sepsis are at high risk of ac-
quiring drug resistant pathogens. Furthermore, the time
taken to change to appropriate antibiotic therapy influ-
enced the outcome of patients with BSI in this study, con-
sistent with other reports [25-27]. It is therefore necessary
to evaluate BSI cases from time to time and adjust the an-
tibiotics accordingly. This is especially important for pa-
tients in a critical condition with septic shock status and
confused consciousness, both of which were prognostic
factors for poor outcomes.
We observed that the patients with BSI from the affili-
ated nursing home had better outcomes in multivariate
analysis. Possible reasons for this are that the patients
from the hospital affiliated nursing home had adequate
medical information. These referral medical informa-
tion includes hospitalization history, previous culture
report, and recent infection sites, these could help the
clinicians to estimate the risk of BSI cases to have mul-
tiple drug resistant pathogens, thereby allowing for a
rapid intervention in the early phase of the BSI at the
hospital, and help the clinicians to choose initial appro-
priate antibiotics.
In this study, old age and having ventilator support
were the most important underlying conditions influen-
cing survival (Table 1). These findings are similar to
those previously reported by Lee et al., in which they
showed that the impact of inappropriate empirical anti-
biotic therapy on the outcomes of elderly patients with
bacteremia was greater than that for younger adults [3].
A meta-analysis of BSI also revealed that inappropriate
antimicrobial therapy significantly increased the odds of
mortality in patients with ventilator support [9].
In this study, E. coli, S. aureus, K. pneumoniae were
the three most common pathogens, which is similar to
previous reports [6,28] with the exception of B. cepacia
bacteremia. However, there was an outbreak of B. cepacia
due to contaminated multiple-dose heparin vials [19].
In addition, our study showed that MRSA led to the
highest inappropriate antibiotic use (80.6%) and the
highest in-hospital mortality rate (64.5%) among all
pathogens. This suggests that local community hospital
physicians may not recognize the risk factors and con-
sequences of MRSA infections, which can be corrected
by identifying the local risk factors for MRSA and con-
tinuing physician education.
Conclusions
In conclusion, a high mortality rate of patients with BSI
was associated with a high rate of inappropriate anti-
biotic therapy in a community hospital in Taiwan. We
observed a better prognosis in patients with BSI from a
hospital-affiliated nursing home, whom were brought to
the hospital with medical information. Efforts should be
made to avoid the administration of inappropriate anti-
biotic therapy or delaying appropriate antibiotics admin-
istration in order to improve the outcomes of patients
with BSI.
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Table 6 The 30-day mortality rate in community
acquired, nursing home acquired and nosocomial
infection were 34.3%, 26.3%, 58.9%
OR P value
Vascular diseases 0.419 0.011
Pulmonary infection 2.341 0.017
UTI 0.349 0.015
ICU stay 3.185 0.001
tracheostomy 0.362 0.003
Septic shock 2.810 0.004
MODS 13.714 0.012
Creatinine 2.6008 ± 1.6870 vs. 1.9296 ± 1.4225 0.014
The significant factors associated with 30-day mortality in univariate analysis
were present in the following table.
UTI Urinary tract infection, ICU Intensive care unit, MODS Multiple organ
dysfunction syndrome.
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